MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRODEL, E. K.
Right arrow Articles by COHEN, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRODEL, E. K.
Right arrow Articles by COHEN, J. B.

Molecular Pharmacology, Vol 15, 294-312, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Identification of a Local Anesthetic Binding Site in Nicotinic Post-Synaptic Membranes Isolated from Torpedo marmorata Electric Tissue

ELIZABETH K. KRODEL 1, ROBERT A. BECKMAN 1, and JONATHAN B. COHEN 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

Studies are presented of the interaction of aromatic amine noncompetitive antagonists with the receptor-rich (post-synaptic) membranes isolated from Torpedo marmorata electric organ. When present at micromolar concentrations, methyl iodide quaternary derivatives of the potent non-competitive antagonists proadifen and dimethisoquin increase the affinity of the membrane-bound nicotinic receptor for [3H]acetylcholine and [14C]dimethyltubocurarine. The equilibrium binding of [14C]meproadifen (2-(diethylmethylamino)ethyl-2,2-diphenyl valerate) to the receptor-rich membranes is characterized by an ultracentrifugatiom assay. When all acetylcholine binding sites are occupied by the agonist carbamylcholine or the antagonist tubocurarine, [14C]meproadifen is bound with a dissociation constant KD = 0.5 µM to a number of sites equal to one-quarter the number of agr-neurotoxin binding sites. That high affinity binding site is found in the receptor-rich membranes and not in other membrane fractions isolated from Torpedo electric organ. Other non-competitive aromatic amino antagonists including dimethisoquin, proadifen, and prilocaine displace [14C]meproadifen, as does perhydrohistrionicotoxin. It is concluded that there is a specific site of binding for the aromatic amine non-competitive antagonists in the isolated nicotinic post-synaptic membrane that is distinct from the site of binding of acetylcholine. Analysis of the interaction of [14C]meproadifen with the receptor-rich membranes in the absence of cholinergic ligands indicates that under these circumstances the ligand binds weakly to both the anesthetic binding site and the acetylcholine binding site (KD = 5 µM). The functional significance of the specific binding site for the aromatic amine non-competitive antagonists is discussed in terms of its possible relation to the site of ion translocatiom and to the mechanism of receptor desensitization.

Note:
ACKNOWLEDGMENTS We are grateful for the expert technical assistance provided by Dan C. Medynski in the early stages of this investigation. We thank Drs. A. Menez, J. L. Morgat, P. Fromageot, and P. Boquet for a gift of the [3H]agr-neurotoxin of N. nigricollis; Prof. Y. Kishi for his gift of H12-HTX, which he and his associates synthesized (26); Dr. B. Takman (Astra Pharmaceuticals) for a gift of prilocaine, lidocaine, and lidocaine ethylbromide; Dr. E. S. Rump (Smith, Kline, and French) for samples of dimethisoquin and proadifen. In addition we are grateful to Dr. C. Cazaux and his colleagues at the Institut de Biologie Marine, Arcachon, for supplying Torpedo and to L. Garibaldi, J. Dayton, and E. Kettle (New England Aquarium) for their maintenance.

Submitted on July 17, 1978
Accepted on October 3, 1978




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. E. Baenziger, S. E. Ryan, M. M. Goodreid, N. Q. Vuong, R. M. Sturgeon, and C. J. B. daCosta
Lipid Composition Alters Drug Action at the Nicotinic Acetylcholine Receptor
Mol. Pharmacol., March 1, 2008; 73(3): 880 - 890.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. E. Ryan and J. E. Baenziger
A Structure-Based Approach to Nicotinic Receptor Pharmacology
Mol. Pharmacol., February 1, 1999; 55(2): 348 - 355.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. M. Lurtz and S. E. Pedersen
Aminotriarylmethane Dyes Are High-Affinity Noncompetitive Antagonists of the Nicotinic Acetylcholine Receptor
Mol. Pharmacol., January 1, 1999; 55(1): 159 - 167.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. E. Ryan, C. N. Demers, J. P. Chew, and J. E. Baenziger
Structural Effects of Neutral and Anionic Lipids on the Nicotinic Acetylcholine Receptor. AN INFRARED DIFFERENCE SPECTROSCOPY STUDY
J. Biol. Chem., October 4, 1996; 271(40): 24590 - 24597.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Changeux, A Devillers-Thiery, and P Chemouilli
Acetylcholine receptor: an allosteric protein
Science, September 21, 1984; 225(4668): 1335 - 1345.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Ryan, M. P. Blanton, and J. E. Baenziger
A Conformational Intermediate between the Resting and Desensitized States of the Nicotinic Acetylcholine Receptor
J. Biol. Chem., February 9, 2001; 276(7): 4796 - 4803.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics